Alyn Davies

Geçmiş katılımlar

• 9th TPD & Induced Proximity Summit

  26–29 Oct 2026Boston, United States of America

  • KonuşmacıDeveloping AURKB PROTACs as a Novel Payload Class for Next-Generation Degrader Antibody Conjugates (DACs)
• 17th World ADC San Diego

  12–15 Oct 2026San Diego, United States of America

  • KonuşmacıPROTAC ADCs: Incorporating Historical Learnings to Navigate Novel Payload Development Beyond Blind Potency

Şu etkinlikteki diğer konuşmacılar: 9th TPD & Induced Proximity Summit

• Stuart Schreiber

  Professor, Harvard Medical School

• Randy Teel

  President & Chief Executive Officer, Arvinas, Inc.

• Carla Bauer

  Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

• Adam Gilbert

  Science Partner, Flagship Pioneering

• Jason Kantor

  Chief Business Officer, Nurix Therapeutics, Inc.

• Giovanni Spagnolli

  Co-Founder & Chief Technology Officer, Sibylla Biotech srl

Etkinlik sayfasında 61 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: 17th World ADC San Diego

• Robert Lutz

  Chief Scientific Officer, Iksuda Therapeutics

• Krishna Bajjuri

  Senior Director, Chemistry, Sutro Biopharma

• Jerome Boyd-Kirkup

  Chief Scientific Officer, Callio Therapeutics

• David Bramhill

  President & Founder, Bramhill Biologics Consulting

• Vinod Bulusu

  Executive Director, Product Stewardship Lead, AstraZeneca

• Nicolas Camper

  Senior Director - Bioconjugation Chemistry, Abzena

Etkinlik sayfasında 39 konuşmacının tümünü gör